The Veteran's blood disorders are being remanded for further examination and opinion regarding their etiology, with a focus on herbicide agent exposure in Vietnam.
The deciding factor: The examiner is required to provide an opinion as to whether the Veteran's blood disorders are at least as likely as not related to his active service, including herbicide agent exposure.
- Claimed conditions
- idiopathic hemorrhagic purpura, monoclonal gammopathy, recurrent blood clots
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- Gulf War
- Rating
- Not verified here — check the original decision
- Decision date
- May 25, 2022
- Citation
- 22030932
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 22030932.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Dismissed
The Board dismissed the appeal concerning service connection for monoclonal gammopathy and multiple myeloma due to the appellant's withdrawal of the appeal prior to a decision.
- Remanded (sent back)
The Board has remanded the claims of service connection for various conditions due to a lack of STRs and personnel records, which may indicate potential exposure to ionizing radiation or toxic exposure during service. The Veteran's participation in a TERA while stationed in Japan is also under review.
- Dismissed
The Board dismissed the appeal for an increased evaluation greater than 20 percent for diabetes mellitus as it was not reasonably raised by the record prior to the Veteran's death.
- Granted
The Board granted service connection for diabetes, hypertension, monoclonal gammopathy, diabetic peripheral neuropathy of the bilateral femoral and sciatic nerves, chronic kidney disease, anemia, and upper extremity diabetic peripheral neuropathy on a direct basis or secondary to diabetes, effective November 5, 2021.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.